ELAN
Price
$14.21
Change
+$0.14 (+1.00%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
7.87B
2 days until earnings call
PAHC
Price
$26.57
Change
-$0.57 (-2.10%)
Updated
Aug 5, 04:59 PM (EDT)
Capitalization
523.71M
22 days until earnings call
Interact to see
Advertisement

ELAN vs PAHC

Header iconELAN vs PAHC Comparison
Open Charts ELAN vs PAHCBanner chart's image
Elanco Animal Health
Price$14.21
Change+$0.14 (+1.00%)
Volume$62.74K
Capitalization7.87B
Phibro Animal Health
Price$26.57
Change-$0.57 (-2.10%)
Volume$1.61K
Capitalization523.71M
ELAN vs PAHC Comparison Chart in %
Loading...
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELAN vs. PAHC commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELAN is a Hold and PAHC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 06, 2025
Stock price -- (ELAN: $14.20 vs. PAHC: $26.59)
Brand notoriety: ELAN: Notable vs. PAHC: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ELAN: 136% vs. PAHC: 77%
Market capitalization -- ELAN: $7.87B vs. PAHC: $523.71M
ELAN [@Pharmaceuticals: Other] is valued at $7.87B. PAHC’s [@Pharmaceuticals: Other] market capitalization is $523.71M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELAN’s FA Score shows that 0 FA rating(s) are green whilePAHC’s FA Score has 0 green FA rating(s).

  • ELAN’s FA Score: 0 green, 5 red.
  • PAHC’s FA Score: 0 green, 5 red.
According to our system of comparison, both ELAN and PAHC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELAN’s TA Score shows that 5 TA indicator(s) are bullish while PAHC’s TA Score has 6 bullish TA indicator(s).

  • ELAN’s TA Score: 5 bullish, 5 bearish.
  • PAHC’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, PAHC is a better buy in the short-term than ELAN.

Price Growth

ELAN (@Pharmaceuticals: Other) experienced а -1.32% price change this week, while PAHC (@Pharmaceuticals: Other) price change was -5.07% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.52%. For the same industry, the average monthly price growth was +63.14%, and the average quarterly price growth was +85.02%.

Reported Earning Dates

ELAN is expected to report earnings on Nov 11, 2025.

PAHC is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.52% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ELAN($7.87B) has a higher market cap than PAHC($524M). PAHC YTD gains are higher at: 30.530 vs. ELAN (16.185). PAHC has higher annual earnings (EBITDA): 83.7M vs. ELAN (-224M). ELAN has more cash in the bank: 352M vs. PAHC (92.5M). PAHC has less debt than ELAN: PAHC (513M) vs ELAN (5.77B). ELAN has higher revenues than PAHC: ELAN (4.42B) vs PAHC (982M).
ELANPAHCELAN / PAHC
Capitalization7.87B524M1,502%
EBITDA-224M83.7M-268%
Gain YTD16.18530.53053%
P/E RatioN/A34.11-
Revenue4.42B982M450%
Total Cash352M92.5M381%
Total Debt5.77B513M1,126%
FUNDAMENTALS RATINGS
ELAN vs PAHC: Fundamental Ratings
ELAN
PAHC
OUTLOOK RATING
1..100
6156
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
10075
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4543
P/E GROWTH RATING
1..100
9388
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ELAN's Valuation (50) in the Agricultural Commodities Or Milling industry is in the same range as PAHC (50) in the Pharmaceuticals Major industry. This means that ELAN’s stock grew similarly to PAHC’s over the last 12 months.

PAHC's Profit vs Risk Rating (75) in the Pharmaceuticals Major industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that PAHC’s stock grew similarly to ELAN’s over the last 12 months.

PAHC's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as ELAN (100) in the Agricultural Commodities Or Milling industry. This means that PAHC’s stock grew similarly to ELAN’s over the last 12 months.

PAHC's Price Growth Rating (43) in the Pharmaceuticals Major industry is in the same range as ELAN (45) in the Agricultural Commodities Or Milling industry. This means that PAHC’s stock grew similarly to ELAN’s over the last 12 months.

PAHC's P/E Growth Rating (88) in the Pharmaceuticals Major industry is in the same range as ELAN (93) in the Agricultural Commodities Or Milling industry. This means that PAHC’s stock grew similarly to ELAN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELANPAHC
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
75%
Bearish Trend 2 days ago
72%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 14 days ago
70%
Declines
ODDS (%)
Bearish Trend 6 days ago
73%
Bearish Trend 5 days ago
71%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
ELAN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PAHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIFAX26.680.23
+0.87%
American Funds Income Fund of Amer F3
GRGRX47.42N/A
N/A
Goldman Sachs Equity Income R
BLRCX11.32N/A
N/A
Brookfield Global Listed Real Estate C
AFDCX50.96N/A
N/A
American Century Large Cap Equity C
BIFRX19.52N/A
N/A
BlackRock International R

ELAN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAN has been loosely correlated with ZTS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAN jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAN
1D Price
Change %
ELAN100%
+2.03%
ZTS - ELAN
49%
Loosely correlated
+3.01%
VTRS - ELAN
47%
Loosely correlated
+1.48%
PAHC - ELAN
41%
Loosely correlated
+3.94%
SNDL - ELAN
39%
Loosely correlated
-0.61%
TLRY - ELAN
36%
Loosely correlated
+6.88%
More

PAHC and

Correlation & Price change

A.I.dvisor indicates that over the last year, PAHC has been loosely correlated with PBH. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PAHC jumps, then PBH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAHC
1D Price
Change %
PAHC100%
+3.94%
PBH - PAHC
51%
Loosely correlated
+0.65%
AMRX - PAHC
47%
Loosely correlated
+1.73%
ZTS - PAHC
41%
Loosely correlated
+3.01%
ELAN - PAHC
40%
Loosely correlated
+2.03%
VTRS - PAHC
38%
Loosely correlated
+1.48%
More